SCHEMBL2096855

SCHEMBL2096855

Cn1c(SCC2CC2)nnc1[C@H](CN1CCOCC1)NC(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.45
KDM4E B2RXH2 6/20 0.45
TSHR P16473 3/20 0.41
TP53 P04637 1/20 0.39
PABPC1 P11940 1/20 0.38
ALOX15 P16050 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RGS12 O14924 1/20 0.37
NPC1 O15118 1/20 0.36
ABL1 P00519 1/20 0.36
RIN1 Q13671 1/20 0.36
POLB P06746 2/20 0.36
HSD17B10 Q99714 4/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2054718 0.88 TSHR (0.38) ALDH1A1KDM4ETSHRTP53PABPC1
SCHEMBL2054699 0.79 ALDH1A1 (0.38) ALDH1A1KDM4ETSHRTP53PABPC1
SCHEMBL8241990 0.69 CYP2C19 (0.47) ALDH1A1KDM4ETSHRTP53ALOX15
SCHEMBL2095703 0.69 ALDH1A1 (0.41) ALDH1A1TSHRL3MBTL1NPC1POLB
SCHEMBL2054714 0.64 ALDH1A1 (0.41) ALDH1A1TSHRL3MBTL1NPC1POLB
SCHEMBL2054703 0.64 ALDH1A1 (0.41) ALDH1A1KDM4ETSHRL3MBTL1NPC1
SCHEMBL22229267 0.64 GPR88 (0.53) ALDH1A1TP53POLBLMNAMAPT
SCHEMBL4148021 0.64 GPR88 (0.53) ALDH1A1TP53POLBLMNAMAPT
SCHEMBL2054710 0.61 ALDH1A1 (0.41) ALDH1A1TSHRTP53ALOX15POLB
SCHEMBL2098763 0.61 POLB (0.36) ALDH1A1TSHRPOLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163956-B2 Inhibitors of GLYT1 transporters MERCK SHARP & DOHME CORP. (US) 2012-04-24 US disclosed
US-20090286765-A1 Therapeutic Agents MERCK SHARP & DOHME (UK) LIMITED (GB) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286765-A1 Therapeutic Agents GRIA1, GRIN1, GLRA1 ALDH1A1 652/4885KDM4E 4416/4885TSHR 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.